DE VITA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 23.685
EU - Europa 7.401
AS - Asia 4.515
SA - Sud America 805
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 8
Totale 36.527
Nazione #
US - Stati Uniti d'America 23.481
UA - Ucraina 2.475
SG - Singapore 2.320
CN - Cina 1.302
DE - Germania 1.212
IT - Italia 941
BR - Brasile 735
FI - Finlandia 629
RU - Federazione Russa 584
SE - Svezia 497
IE - Irlanda 475
KR - Corea 257
GB - Regno Unito 233
TR - Turchia 202
CA - Canada 168
IN - India 96
FR - Francia 92
VN - Vietnam 86
HK - Hong Kong 74
AT - Austria 54
IR - Iran 43
NL - Olanda 38
CZ - Repubblica Ceca 32
EU - Europa 27
BE - Belgio 26
JP - Giappone 25
MX - Messico 24
AR - Argentina 23
TG - Togo 22
PL - Polonia 20
ZA - Sudafrica 20
MA - Marocco 18
IQ - Iraq 14
UZ - Uzbekistan 14
ES - Italia 12
GR - Grecia 12
BD - Bangladesh 11
CL - Cile 11
PT - Portogallo 11
EC - Ecuador 10
EG - Egitto 10
PK - Pakistan 10
RO - Romania 9
AU - Australia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
HR - Croazia 6
NO - Norvegia 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
BO - Bolivia 5
EE - Estonia 5
ID - Indonesia 5
IL - Israele 5
AL - Albania 4
CO - Colombia 4
KE - Kenya 4
KG - Kirghizistan 4
LK - Sri Lanka 4
LT - Lituania 4
LV - Lettonia 4
PE - Perù 4
PH - Filippine 4
TW - Taiwan 4
UY - Uruguay 4
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HU - Ungheria 3
PA - Panama 3
CY - Cipro 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 36.523
Città #
Woodbridge 3.780
Ann Arbor 2.593
Fairfield 2.014
Houston 1.956
Jacksonville 1.764
Chandler 1.521
Singapore 1.251
Ashburn 1.023
Wilmington 1.003
Dearborn 966
Beijing 732
Seattle 707
Boardman 615
Cambridge 614
Dublin 472
Princeton 466
Udine 304
Seoul 238
Izmir 190
San Diego 184
Munich 131
Ottawa 130
Ogden 104
Des Moines 103
Norwalk 92
Dong Ket 78
Helsinki 76
Hong Kong 65
Los Angeles 61
New York 61
Nanjing 57
São Paulo 57
Hefei 56
Redmond 53
Nuremberg 52
Trieste 48
Guangzhou 44
San Mateo 43
Falls Church 41
Kunming 41
Santa Clara 32
Milan 30
London 29
Rome 29
Brno 26
Düsseldorf 26
Belo Horizonte 25
Brussels 25
Andover 24
Augusta 24
Frankfurt am Main 24
Simi Valley 24
Lomé 22
Shanghai 22
Lauterbourg 21
Leawood 21
Vienna 21
Grafing 20
Nanchang 19
Warsaw 19
Phoenix 18
Toronto 17
Turku 17
Washington 17
Auburn Hills 16
Dallas 16
Fuzhou 16
Amsterdam 15
Ardabil 15
Belluno 15
Jinan 15
Wuhan 15
Zhengzhou 15
Brasília 14
Mumbai 14
Redwood City 14
Monmouth Junction 13
Salvador 13
Shenyang 13
Tashkent 13
Brooklyn 12
Hyderabad 12
Johannesburg 12
Ribeirão Preto 12
Rio de Janeiro 12
Montreal 11
Naples 11
Atlanta 10
Boston 10
Moscow 10
Saint Louis 10
Verona 10
Chengdu 9
Chongqing 9
Curitiba 9
Paris 9
Portsmouth 9
Pune 9
San Francisco 9
Tappahannock 9
Totale 24.774
Nome #
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 280
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 167
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients 164
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 156
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: A nationwide multi-center retrospective observational study 155
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 152
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. 152
Absence of human parvovirus B19 DNA in myoepithelial sialadenitis of primary Sjögren's syndrome. 150
Validation of the classification criteria for cryoglobulinaemic vasculitis. 149
Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study 148
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 147
Terapia dell'artrite reumatoide con immunoglobuline per via endovenosa ad alte dosi: esperienza clinica e revisione della letteratura 147
B-cell lymphomas associated with HCV infection 145
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 144
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts 143
Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma 140
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 137
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 136
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 136
Efficacy and safety of rituximab in type II mixed cryoglobulinemia. 133
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 133
Use of teriparatide in osteoporosis due to active rheumatic diseases 132
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. 132
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 131
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 131
Misoprostol-induced urinary incontinence 131
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 131
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 130
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 129
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 129
BLyS and April serum levels in patients with autoimmune thyroid diseases. 128
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 127
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 126
Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. 125
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. 124
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 124
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 124
Plasmocitoma micromolecolare osteosclerotico 123
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 123
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 123
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 123
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 123
Frequent detection of human herpesvirus 6 DNA in HIV-associated lymphadenopathy. 122
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 122
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 122
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 122
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 122
Medical data quality assessment: On the development of an automated framework for medical data curation 122
Subtypes of Epstein-Barr virus in HIV-1-associated and HIV-1-unrelated Hodgkin's disease cases. 122
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 121
SALIVARY GLAND ECHOGRAPHY IN PRIMARY AND SECONDARY SJOGREN'S SYNDROME 121
Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer 121
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 121
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 120
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 120
Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. 119
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 119
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 119
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 118
B cell driving cytokines in eraly rheumatoid arthritis. Assessment of possibile clonal expansions during treatment with cyclosporin A. Arthritis and Rheumatism 1996; 39 (Suppl.): S26. 118
Multifocal ischemic necrosis of bone in scleroderma. 118
Leflunomide for active rheumatoid arthritis 118
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 118
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 117
Rarity of microsatellite genomic instability in B-cell non-Hodgkin's lymphomas in hepatitis C virus-infected patients 117
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 116
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 116
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 115
Classification of cryoglobulinemic vasculitis 114
Rituximab for the treatment of type II mixed cryoglobulinemia. 114
Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue 114
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 114
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 114
Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. 113
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 113
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 112
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). 112
General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus 112
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 112
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 112
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 112
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 111
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus 111
Gastrointestinal Involvement in Systemic Vasculitis 110
True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. 108
Clinical differences between ANA/anti-ENA positive or negative primary Sjögren's syndrome 108
Book review: L'actualité rhumatologique 1990 présentée au praticien 108
Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. 107
Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. . 107
Emerging drugs for primary Sjögren’s syndrome 107
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. 106
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 106
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. 106
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 106
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 106
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 105
Efficacy of selective B cell Blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells 105
Combinad therapy with cyclobenzaprina and ipuprofen in primary fibromialgia sindrome 105
Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome 104
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 103
Totale 12.486
Categoria #
all - tutte 147.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020567 0 0 0 0 0 0 0 0 0 0 0 567
2020/20214.606 137 536 87 543 103 580 126 529 924 139 663 239
2021/20223.523 89 403 162 380 108 105 156 232 48 532 673 635
2022/20233.839 515 167 69 427 393 1.043 33 287 574 56 114 161
2023/20241.238 179 120 47 26 223 190 51 93 168 67 24 50
2024/20256.470 202 606 300 238 391 413 451 581 931 765 1.402 190
Totale 37.437